Addex outlines its business plans
This article was originally published in Scrip
Executive Summary
Addex Pharmaceuticals is in no hurry to partner its products. Insteadit might wait until the pharmaceutical market is less biased towards buyers, Laurent Massuyeau, the company's head of business development, told Scrip at the recent BIO-Europe Spring conference.